ADAP - Adaptimmune Q3 2022 Earnings Preview
- Adaptimmune ( NASDAQ: ADAP ) is scheduled to announce Q3 earnings results on Tuesday, November 8th, before market open.
- The consensus EPS Estimate is -$0.28 (-460.0% Y/Y) and the consensus Revenue Estimate is $4.97M (+314.2% Y/Y).
- Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward.
- Over the last 2 years, ADAP has beaten EPS estimates 50% of the time and has beaten revenue estimates 50% of the time.
For further details see:
Adaptimmune Q3 2022 Earnings Preview